Xeris Biopharma Holdings Inc reports results for the quarter ended September 30 - Earnings Summary

Xeris Biopharma Holdings

08/11/2024 16:24

* Xeris Biopharma Holdings Inc  XERS.OQ  reported a
quarterly
adjusted loss of 11 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -9 cents.  The mean expectation of
six analysts for the quarter was for a loss of 9 cents per
share. Wall Street expected results to range from -10 cents
to -6 cents per share.
    * Revenue rose 12.3% to $54.27 million from a year ago;
analysts
expected $51.43 million. 
    * Xeris Biopharma Holdings Inc's reported EPS for the
quarter was
a loss of 11 cents​.
    * The company reported a quarterly loss of $15.74 million.
    * Xeris Biopharma Holdings Inc shares had risen by 17.9%
this
quarter and gained 43.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 5.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "buy."

Wall Street's median 12-month price target for Xeris Biopharma
Holdings Inc is $5.00 
This summary was machine generated from LSEG data November 8 at
04:24 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.09          -0.11          Missed
 Jun. 30 2024      -0.11          -0.10          Beat
 Mar. 31 2024                     -0.14          
 Dec. 31 2023      -0.10          -0.10          Met